SCHEMBL4894729

SCHEMBL4894729

CC(C)OC(=O)NCc1cc(OCCCCOc2ccc(Oc3ccccc3)cc2)ccc1CCC(=O)O

nearest known ligand 0.70

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PPARG P37231 16/20 0.70
PPARA Q07869 15/20 0.70
PPARD Q03181 5/20 0.48
LTA4H P09960 1/20 0.47
FFAR1 O14842 3/20 0.43
FFAR4 Q5NUL3 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4893870 0.98 PPARG (0.70) PPARGPPARAPPARDLTA4HFFAR1
SCHEMBL4896415 0.90 PPARG (0.72) PPARGPPARAPPARDLTA4HFFAR1
SCHEMBL4885651 0.89 PPARG (0.73) PPARGPPARAPPARDLTA4HFFAR1
SCHEMBL4888126 0.88 PPARG (0.68) PPARGPPARAPPARDFFAR1FFAR4
SCHEMBL4898434 0.83 PPARG (0.51) PPARGPPARAPPARDLTA4HFFAR1
SCHEMBL4894529 0.83 PPARG (1.00) PPARGPPARAPPARD
SCHEMBL4896302 0.81 PPARG (0.61) PPARGPPARA
SCHEMBL4888371 0.81 PPARG (0.51) PPARGPPARAPPARDLTA4HFFAR1
SCHEMBL4891617 0.81 PPARG (0.90) PPARGPPARAPPARD
SCHEMBL4893180 0.80 PPARG (0.51) PPARGPPARAPPARDLTA4HFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080167310-A1 MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS (PPAR) GOSSETT LYNN STACY 2008-07-10 US disclosed
US-20080167310-A1 MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS (PPAR) GOSSETT LYNN STACY 2008-07-10 US disclosed
US-20080167310-A1 MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS (PPAR) GOSSETT LYNN STACY 2008-07-10 US disclosed
US-7282501-B2 Modulators of peroxisome proliferator activated receptors (PPAR) ELI LILLY AND COMPANY (US) 2007-10-16 US disclosed
US-7282501-B2 Modulators of peroxisome proliferator activated receptors (PPAR) ELI LILLY AND COMPANY (US) 2007-10-16 US disclosed
US-7282501-B2 Modulators of peroxisome proliferator activated receptors (PPAR) ELI LILLY AND COMPANY (US) 2007-10-16 US disclosed
US-20050075378-A1 Modulators of peroxisome proliferator activated receptors (ppar) ELI LILLY AND COMPANY 2005-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050075378-A1 Modulators of peroxisome proliferator activated receptors (ppar) PPARG, PPARA, PPARD PPARG 1/4885PPARA 2/4885PPARD 3/4885
US-20080167310-A1 MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS (PPAR) PPARG, PPARA, PPARD PPARG 1/4885PPARA 2/4885PPARD 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.